The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Zhao, J.-J., Lin, J., Yang, H., Kong, W., He, L., Ma, X., Coppola, D., & Cheng, J. Q. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m806041200 · Cited by 509
RetractedAnalysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Real-time quantification of microRNAs by stem-loop RT-PCR
Chen, C. (2005) · Nucleic Acids Research · doi:10.1093/nar/gni178 · Cited by 4,952
The Release of Cytochrome c from Mitochondria: A Primary Site for Bcl-2 Regulation of Apoptosis
Kluck, R. M., Bossy-Wetzel, E., Green, D. R., & Newmeyer, D. D. (1997) · Science · doi:10.1126/science.275.5303.1132 · Cited by 4,714
MicroRNA-21 Is an Antiapoptotic Factor in Human Glioblastoma Cells
Chan, J. A., Krichevsky, A. M., & Kosik, K. S. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-0137 · Cited by 2,557
Si, M.-L., Zhu, S., Wu, H., Lu, Z., Wu, F., & Mo, Y.-Y. (2007) · Oncogene · doi:10.1038/sj.onc.1210083 · Cited by 1,600
miR‐21: a small multi‐faceted RNA
Krichevsky, A. M., & Gabriely, G. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2008.00556.x · Cited by 987
Meng, F., Henson, R., Lang, M., Wehbe, H., Maheshwari, S., Mendell, J. T., Jiang, J., Schmittgen, T. D., & Patel, T. (2006) · Gastroenterology · doi:10.1053/j.gastro.2006.02.057 · Cited by 984
MicroRNA 21 Promotes Glioma Invasion by Targeting Matrix Metalloproteinase Regulators
Gabriely, G., Wurdinger, T., Kesari, S., Esau, C. C., Burchard, J., Linsley, P. S., & Krichevsky, A. M. (2008) · Molecular and Cellular Biology · doi:10.1128/mcb.00479-08 · Cited by 888 · cited 1×
“Inhibiting miR-21 expression leads to proliferation inhibition and apoptotic cell death in multiple glioblastoma cell lines (Silber et al., 2009; Conti et al., 2009; Corsten et al., 2007; Shi et al., 2008; Gabriely et al., 2008; Chan et al., 2005).”
BackgroundMicroRNA-221/222 Confers Tamoxifen Resistance in Breast Cancer by Targeting p27Kip1
Miller, T. E., Ghoshal, K., Ramaswamy, B., Roy, S., Datta, J., Shapiro, C. L., Jacob, S., & Majumder, S. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m804612200 · Cited by 749
MicroRNAs and small interfering RNAs can inhibit mRNA expression by similar mechanisms
Zeng, Y., Yi, R., & Cullen, B. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1630797100 · Cited by 741
Regulation and function of the p53 tumor suppressor protein
Ryan, K. M., Phillips, A. C., & Vousden, K. H. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00216-7 · Cited by 721
MicroRNA-21 Targets a Network of Key Tumor-Suppressive Pathways in Glioblastoma Cells
Papagiannakopoulos, T., Shapiro, A., & Kosik, K. S. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-1305 · Cited by 705 · cited 1×
“MiR-21, which was significantly elevated in glioblastoma and regulated multiple genes associated with cancer cell proliferation, apoptosis, and invasiveness, functioned as an antiapoptotic factor in cultured glioblastoma multiforme cells (Papagiannakopoulos et al., 2008).”
BackgroundKovalchuk, O., Filkowski, J., Meservy, J., Ilnytskyy, Y., Tryndyak, V. P., Chekhun, V. F., & Pogribny, I. P. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0021 · Cited by 635
MiR-21 Indicates Poor Prognosis in Tongue Squamous Cell Carcinomas as an Apoptosis Inhibitor
Li, J., Huang, H., Sun, L., Yang, M., Pan, C., Chen, W., Wu, D., Lin, Z., Zeng, C., Yao, Y., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3053 · Cited by 434
hsa-mir-181a and hsa-mir-181b function as tumor suppressors in human glioma cells
Shi, L., Cheng, Z., Zhang, J., Li, R., Zhao, P., Fu, Z., & You, Y. (2008) · Brain Research · doi:10.1016/j.brainres.2008.07.085 · Cited by 430
Self-citationCorsten, M. F., Miranda, R., Kasmieh, R., Krichevsky, A. M., Weissleder, R., & Shah, K. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1045 · Cited by 406
Hirose, Y., Berger, M. S., & Pieper, R. O. (2001) · PubMed · Cited by 333
Agarwala, S. S., & Kirkwood, J. M. (2000) · The Oncologist · doi:10.1634/theoncologist.5-2-144 · Cited by 330
Salakou, S., Kardamakis, D. M., Tsamandas, A. C., Zolota, V., Apostolakis, E. E., Tzelepi, V., Papathanasopoulos, P., Bonikos, D. S., Papapetropoulos, T., Petsas, T. G., et al. (2007) · PubMed · Cited by 306
Athanassiou, H., Synodinou, M., Maragoudakis, E., Paraskevaidis, M., Verigos, C., Misailidou, D., Antonadou, D., Saris, G., Beroukas, K., & Karageorgis, P. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.00.331 · Cited by 272
Bcl-2 and Bcl-XL Can Differentially Block Chemotherapy-Induced Cell Death
Simonian, P. L., Grillot, D. A. M., & Nuñez, G. (1997) · Blood · doi:10.1182/blood.v90.3.1208 · Cited by 242
Current tools for the identification of miRNA genes and their targets
Mendes, N. D., Freitas, A. T., & Sagot, M.-F. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp145 · Cited by 235
Groves, M. D., Puduvalli, V. K., Hess, K. R., Jaeckle, K. A., Peterson, P., Yung, W. K. A., & Levin, V. A. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.5.1383 · Cited by 229
miR-21 and 221 upregulation and miR-181b downregulation in human grade II–IV astrocytic tumors
Conti, A., Aguennouz, M., La Torre, D., Tomasello, C., Cardali, S., Angileri, F. F., Maio, F., Cama, A., Germanò, A., Vita, G., et al. (2009) · Journal of Neuro-Oncology · doi:10.1007/s11060-009-9797-4 · Cited by 229
Temozolomide-Mediated Radiation Enhancement in Glioblastoma: A Report on Underlying Mechanisms
Chakravarti, A., Erkkinen, M. G., Nestler, U., Stupp, R., Mehta, M., Aldape, K., Gilbert, M. R., Black, P. M., & Loeffler, J. S. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-0596 · Cited by 223
Ren, Y., Zhou, X., Mei, M., Yuan, X.-B., Han, L., Wang, G.-X., Jia, Z.-F., Xu, P., Pu, P.-Y., & Kang, C.-S. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-27 · Cited by 216
Terrano, D. T., Upreti, M., & Chambers, T. C. (2010) · Molecular and Cellular Biology · doi:10.1128/mcb.00882-09 · Cited by 215
Jarskog, L. F., Selinger, E. S., Lieberman, J. A., & Gilmore, J. H. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.1.109 · Cited by 205
Ren, Y., Kang, C.-S., Yuan, X.-B., Zhou, X., Xu, P., Han, L., Wang, G. X., Jia, Z., Zhong, Y., Yu, S., et al. (2010) · Journal of Biomaterials Science, Polymer Edition · doi:10.1163/156856209x415828 · Cited by 175
Impact of normalization on miRNA microarray expression profiling
Pradervand, S., Weber, J., Thomas, J., Bueno, M., Wirapati, P., Lefort, K., Dotto, G. P., & Harshman, K. (2009) · RNA · doi:10.1261/rna.1295509 · Cited by 173
Differential Regulation of Bax and Bak by Anti-apoptotic Bcl-2 Family Proteins Bcl-B and Mcl-1
Zhai, D., Jin, C., Huang, Z., Satterthwait, A. C., & Reed, J. C. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m708426200 · Cited by 145
Multifaceted resistance of gliomas to temozolomide.
Bocangel, D., Finkelstein, S. D., Schold, S. C., Bhakat, K. K., MITRA, S. P., & Kokkinakis, D. M. (2002) · PubMed · Cited by 135
Manero, F., Gautier, F., Gallenne, T., Cauquil, N., Gree, D. M., Cartron, P., Geneste, O., Gree, R. L., Vallette, F. M., & Juin, P. P. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2097 · Cited by 135
Chekhun, V. F., Lukianova, N. Y., Kovalchuk, O., Tryndyak, V., & Pogribny, I. P. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-06-0663 · Cited by 131
Treatment of recurrent malignant gliomas with high-dose 13-cis-retinoic acid.
Yung, W. K. A., Kyritsis, A. P., Gleason, M. J., & Levin, V. A. (1996) · PubMed · Cited by 122
Roberti, A., Sala, D. L., & Cinti, C. (2005) · Journal of Cellular Physiology · doi:10.1002/jcp.20515 · Cited by 107
Das, A., Banik, N. L., Patel, S. J., & Ray, S. K. (2004) · Molecular Cancer · doi:10.1186/1476-4598-3-36 · Cited by 105
Expression level of Bcl-2 determines anti- or proapoptotic function.
Shinoura, N., Yoshida, Y., Nishimura, M., Muramatsu, Y., Asai, A., Kirino, T., & Hamada, H. (1999) · PubMed · Cited by 104
Cartron, P., Oliver, L., Martin, S. A., Moreau, C., Cabellec, M. L., Jézéquel, P., Méflah, K., & Vallette, F. M. (2002) · Human Molecular Genetics · doi:10.1093/hmg/11.6.675 · Cited by 103
Clarke, M. J., Mulligan, E. A., Grogan, P. T., Mladek, A. C., Carlson, B. L., Schroeder, M. A., Curtin, N. J., Lou, Z., Decker, P. A., Wu, W., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0854 · Cited by 96
Wick, W., Grimmel, C., Wild‐Bode, C., Platten, M., Arpin, M., & Weller, M. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-10-03360.2001 · Cited by 90
Mismatch Repair Deficiency Does Not Mediate Clinical Resistance to Temozolomide in Malignant Glioma
Maxwell, J. A., Johnson, S. P., McLendon, R. E., Lister, D. W., Horne, K. S., Rasheed, A., Quinn, J. A., Ali‐Osman, F., Friedman, A. H., Modrich, P. L., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4807 · Cited by 87
microRNAs in Gliomas: Small Regulators of a Big Problem
Silber, J., James, C. D., & Hodgson, J. (2009) · NeuroMolecular Medicine · doi:10.1007/s12017-009-8087-9 · Cited by 83
Nagane, M., Kobayashi, K., Ohnishi, A., Shimizu, S., & Shiokawa, Y. (2007) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hym132 · Cited by 62
Annexin V staining during reperfusion detects cardiomyocytes with unique properties
Narayan, P., Mentzer, R. M., & Lasley, R. D. (2001) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.2001.281.5.h1931 · Cited by 39
Son, M. J., Kim, J.-S., Kim, M.-K., Song, H. B., Kim, J., Kim, H., Shin, T., Jeon, H., Lee, D. S., Park, S.-Y., et al. (2006) · International Journal of Oncology · doi:10.3892/ijo.28.1.53 · Cited by 35
Prokopenko, O., & Mirochnitchenko, O. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00675.2008 · Cited by 11
Cited by
Liang, G., Zhu, Y., Ali, D. J., Tian, T., Xu, H., Si, K., Sun, B., Chen, B., & Xiao, Z. (2020) · Journal of Nanobiotechnology · doi:10.1186/s12951-019-0563-2 · Cited by 619
Emerging role of microRNA-21 in cancer
Feng, Y.-H., & Tsao, C.-J. (2016) · Biomedical Reports · doi:10.3892/br.2016.747 · Cited by 454
Mechanisms of temozolomide resistance in glioblastoma - a comprehensive review
Singh, N., Miner, A., Hennis, L., & Mittal, S. (2020) · Cancer Drug Resistance · doi:10.20517/cdr.2020.79 · Cited by 398
Apoptosis and the target genes of microRNA-21
Buscaglia, L. E. B., & Li, Y. (2011) · Chinese Journal of Cancer · doi:10.5732/cjc.011.10132 · Cited by 378
Prognostic and Predictive Biomarkers in Gliomas
Śledzińska, P., Bebyn, M. G., Furtak, J., Kowalewski, J., & Lewandowska, M. A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910373 · Cited by 340
Metadata
- Authors
- Shi, L., Chen, J., Yang, J., Pan, T., Zhang, S., & Wang, Z.
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2010-09
- Volume
- 1352
- Pages
- 255-264
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2081297751
- Cited by
- 343
- References
- 48
- FWCI
- 8.31
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.